Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects

HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS

Thomas Walle, Faye Hsieh, Mark H. DeLegge et al. · Drug Metabolism and Disposition · 2004 · 1.8K citations

Pharmacy, Pharmacokinetics, Pharmacology +15

The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease

C.R. Pace-Asciak, Susan Hahn, Eleftherios P. Diamandis et al. · Clinica Chimica Acta · 1995 · 871 citations

Medicine, Cardiology, Pharmacology +16

Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent

David J. Boocock, Guy Faust, Ketan Patel et al. · Cancer Epidemiology Biomarkers & Prevention · 2007 · 816 citations

Medicine, Pharmacokinetics, Pharmacology +11

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

David M. Goldberg, Joseph Yan, George J. Soleas · Clinical Biochemistry · 2003 · 676 citations

Agriculture, Biochemistry, Nutritional Sciences +15

Resveratrol protects against global cerebral ischemic injury in gerbils

Qun Wang, Jianfeng Xu, George E. Rottinghaus et al. · Brain Research · 2002 · 525 citations

Life Sciences, Neurobiology, Neuroscience +11